Scleromyxedema in an HCV-positive male
DOI:
https://doi.org/10.66344/jpad.18.2.2008.578Keywords:
Scleromyxedema, lichen myxedematosus, HCVAbstract
Scleromyxedema is rare chronic cutaneous mucinosis usually associated with a monoclonal gammopathy and underlying systemic disease.We report a 42-year-old male who developed scleromyxedema and was also HCV positive.ÂReferences
Sarkany RPE, Breathnach SM, Seymour CA et al. Metabolic and nutritional disorders. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook’s Textbook of Dermatology.7th edn. London: Blackwell Science; 2004. p. 57.1-83.
Bari AU. Rashid M, Rahman SR. Acral persistent mucinosys: a rare variant of cutaneous mucinoses. J Pak Assoc Dermatol 2004; 14: 253-6.
Banno H, Takamo H, Nitta Y et al. Lichen myxedematosus associated with chronic hepatitis C. Int J Dermatol 2000; 39: 212-4.
Rongioletti F. Lichen myxedematosus (papular mucinoses): new concepts and perspective for an old disease. Semin Cutan Med Surg 2006; 25: 100-4.
Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-81.
Korber A, Frankson T, Graffe S, Dissemond J. Successful therapy of scleromyxedema with low dose intravenous immunoglobulin. J Eur Acad Dermatol Venerol 2007; 21: 553-4.
Rampino M, Garibaldi E, Ragona R, Ricardi U. Scleromyxedema: treatment of widespread cutaneous involvement by total skin electron beam therapy. Int J Dermatol 2007; 46: 864-7.
Lin YC, Wang HC, Shen JL. Scleromyxedema. An experience using corticosteroid and review of the published work. J Am Acad Dermatol 2006; 33: 207-10.
Lo P-Y, Tzung T-Y. Lichen myxedematosus in a patient with hepatocellular carcinoma. Br J Dermatol 2000; 143: 452-3.
Rongioletti F, Rebora A. Worsening of lichen myxedematosus during interferon alfa-2a therapy for chronic active hepatitis C. J Am Acad Dermatol 1998; 38: 760-1.
Masaki S, Nisho Y. Lichen myxedematosus associated with liver cirrhosis. Hihubyou-Shinryou 1994; 16: 29-32 (in Japanese).
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
